Тезис

ISO/TR 12417-2:2017 provides region-specific information for

- local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;

- changes related to the drug containing part and how they are evaluated by the different local regions.

For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.

ISO/TR 12417-2:2017 is considered also as a supplement to ISO 12417‑1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. Requirements listed in this document also address VDDCPs that are not necessarily permanent implants.


Общая информация 

  • Текущий статус
     :  Withdrawn
    Дата публикации
     : 2017-11
  • Версия
     : 1
  • Технический комитет
     : ISO/TC 150/SC 2 Cardiovascular implants and extracorporeal systems
  • ICS
     :
    11.040.40 Implants for surgery, prosthetics and orthotics

Жизненный цикл


Появились вопросы?

Ознакомьтесь с FAQ

Работа с клиентами
+41 22 749 08 88

Часы работы:
Понедельник – пятница: 09:00-12:00, 14:00-17:00 (UTC+1)

Будьте в курсе актуальных новостей ИСО

Подписывайтесь на наши новости, обзоры, а также на информацию о продуктах.

  2. Интернет-магазин
  3. Каталог стандартов
  4. ТК
  5. ISO/TC 150/SC 2
  6. ISO/TR 12417-2:2017